跳至主要内容
临床试验/NCT04546152
NCT04546152已完成不适用

Prospective Observational Clinical Trial for Safety and Efficacy of HYAPROF® SOFT and HYAPROF® BALANCE

BioSCIENCE GmbH2 个研究点 分布在 1 个国家目标入组 170 人开始时间: 2020年9月16日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
170
试验地点
2
主要终点
Number of subjects with wrinkle severity improvement 3 months

研究概览

简要总结

Purpose of this study is the demonstration of safety and efficacy of the dermal fillers HYAPROF® SOFT and HYAPROF® BALANCE for restoration of the facial volume and contour.

详细描述

This is a prospective, multicenter, observational, open label, two-arm, crossover, PMCF clinical trial for demonstration of the safety and efficacy of the HA-based dermal fillers HYAPROF® SOFT and HYAPROF® BALANCE for restoration of the facial volume and contour. Besides safety aspects, evaluated immediately after the treatment, 4 weeks, 3 and 6 months after the treatment, the performance of the demal fillers are evaluated in the 3 and 6 months follow-up by using GAIS and WSRS.

研究设计

研究类型
Observational
观察模型
Case Crossover
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • subjects intended for the treatment with HYAPROF® SOFT and/or BALANCE according to the instructions for use of the product
  • decision for the treatment with HYAPROF® SOFT and/or BALANCE was made before the subject was recruited for the clinical trial
  • subjects signed written informed consent
  • adult subjects at least 18 years old
  • all Fitzpatrick skin types
  • area treated either with HYAPROF® SOFT or HYAPROF® BALANCE - no combination of the products in one treated area

排除标准

  • tendency to hypertrophic and keloid scarring
  • intolerance to gram-positive bacteria
  • prone to active inflammatory or infectious processes
  • suffering from acute or chronic skin diseases
  • undergoing anti-coagulant therapy
  • known allergy to hyaluronic acid
  • suffering from autoimmune diseases
  • multiple allergies
  • pregnancy or lactating women
  • subjects unlikely to cooperate in the clinical investigation or to comply with the treatment or with the clinical investigation visits

结局指标

主要结局

Number of subjects with wrinkle severity improvement 3 months

时间窗: 3 months

Number of subjects with at least one scale point improvement in the wrinkle severity assessment (WSRS) with respect to baseline

Wrinkle severity assessment 3 months

时间窗: 3 months

Wrinkle severity assessment acc. to the Wrinkle Severity Rating Scale (WSRS); 1: wrinkles absent, 2: slight wrinkles, 3: moderate wrinkles, 4: severe wrinkles, 5: very severe wrinkles

Wrinkle severity assessment 6 months

时间窗: 6 months

Wrinkle severity assessment acc. to the Wrinkle Severity Rating Scale (WSRS); 1: wrinkles absent, 2: slight wrinkles, 3: moderate wrinkles, 4: severe wrinkles, 5: very severe wrinkles

Number of subjects with wrinkle severity improvement 6 months

时间窗: 6 months

Number of subjects with at least one scale point improvement in the wrinkle severity assessment (WSRS) with respect to baseline

Global aesthetic improvement 3 months

时间窗: 3 months

Global aesthetic improvement assessment acc. to the Global Aesthetic Improvement Scale (GAIS); 3: very much improved, 2: much improved, 1: improved, 0 unchanged, -1: worse

Global aesthetic improvement 6 months

时间窗: 6 months

Global aesthetic improvement assessment acc. to the Global Aesthetic Improvement Scale (GAIS); 3: very much improved, 2: much improved, 1: improved, 0 unchanged, -1: worse

次要结局

  • Product safety 3 months(3 months)
  • Product safety 4 weeks(4 weeks)
  • Product safety immediately after the treatment(Immediately after the treatment)
  • Product safety 6 months(6 months)

研究者

发起方
BioSCIENCE GmbH
申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验